The DOI matches its Crossref record; 260 of the 260 references it cites were found in a registry or an index.
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
Abstract
IGF-I receptor (IGF-IR) signaling and functions are mediated through the activities of a complex molecular network of positive (e.g., type I IGF) and negative (e.g., the type II IGF receptor, IGF-IIR) effectors. Under normal physiological conditions, the balance between the expression and activities of these molecules is tightly controlled. Changes in this delicate balance (e.g., overexpression of one effector) may trigger a cascade of molecular events that can ultimately lead to malignancy. In recent years, evidence has been mounting that the IGF axis may be involved in human cancer progression and can be targeted for therapeutic intervention. Here we review old and more recent evidence on the role the IGF system in malignancy and highlight experimental and clinical studies that provide novel insights into the complex mechanisms that contribute to its oncogenic potential. Controversies arising from conflicting evidence on the relevance of IGF-IR and its ligands to human cancer are discussed. Our review highlights the importance of viewing the IGF axis as a complex multifactorial system and shows that changes in the expression levels of any one component of the axis, in a given malignancy, should be interpreted with caution and viewed in a wider context that takes into account the expression levels, state of activation, accessibility, and functionality of other interacting components. Because IGF targeting for anticancer therapy is rapidly becoming a clinical reality, an understanding of this complexity is timely because it is likely to have an impact on the design, mode of action, and clinical outcomes of newly developed drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–260 of 260
Kiepe, D., Ciarmatori, S., Hoeflich, A., Wolf, E., & Tönshoff, B. (2005) · Endocrinology · doi:10.1210/en.2005-0324 · Cited by 71
Dai, Z., Xing, Y., Boney, C. M., et al. (1994) · Endocrinology · doi:10.1210/endo.135.4.7523094 · Cited by 71
Mason, H. D., Margara, R. A., Winston, R. M. L., Seppälä, M. T., Koistinen, R. A., & Franks, S. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.5.7684393 · Cited by 71
Insulin-like Growth Factor-II Regulates PTEN Expression in the Mammary Gland
Moorehead, R. A., Hojilla, C. V., de Belle, I., Wood, G. A., Fata, J. E., Adamson, E. D., Watson, K. L. M., Edwards, D. R., & Khokha, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306894200 · Cited by 70
Mercapide, J., de Cicco, R. L., Bassi, D., Castresana, J. S., Thomas, G., & Klein–Szanto, A. J. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0489 · Cited by 70
Germain‐Lee, E. L., Janicot, M., Lammers, R., et al. (1992) · Biochemical Journal · doi:10.1042/bj2810413 · Cited by 69
Forbes, B. E., Hartfield, P. J., McNeil, K. A., Surinya, K. H., Milner, S. J., Cosgrove, L. J., & Wallace, J. C. (2002) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02735.x · Cited by 68
Endometrial Cancer and the IGF System: A Case-Control Study in Greece
Petridou, E. T., Koukoulomatis, P., Alexe, D. M., Voulgaris, Z., Spanos, E., & Trichopoulos, D. (2003) · Oncology · doi:10.1159/000070291 · Cited by 68
Pennisi, P. A., Barr, V. A., Núñez, N. P., STANNARD, B. S., & Roith, D. L. (2002) · PubMed · Cited by 65
Dricu, A., Wang, M., Hjertman, M., Malec, M., Blegen, H., Wejde, J., Carlberg, M., & Larsson, O. (1997) · Glycobiology · doi:10.1093/glycob/7.5.625 · Cited by 65
Ling, Y., Maile, L. A., & Clemmons, D. R. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0143 · Cited by 64
Samani, A. A., & Brodt, P. (2001) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30066-8 · Cited by 64
Self-citationNakamura, K., Hongo, A., Kodama, J., Miyagi, Y., Yoshinouchi, M., & Kudo, T. (2000) · PubMed · Cited by 63
Yan, L., Maile, L. A., Lieskovská, J., Badley-Clarke, J., & Clemmons, D. R. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-10-0918 · Cited by 63
Liu, Y., Lehar, S. M., Corvi, C., Payne, G., & O’Connor, R. (1998) · PubMed · Cited by 62
Yu, D. H., Watanabe, H., Shibuya, H., & Miura, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209809200 · Cited by 61
Mauro, L., Bartucci, M., Morelli, C., Andò, S., & Surmacz, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106673200 · Cited by 61
Dysregulation of IGF-I signaling in uterine leiomyoma
Burroughs, K. D., Howe, S. R., Okubo, Y., Fuchs‐Young, R., LeRoith, D., & Walker, C. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1720083 · Cited by 59
Self-citationArmengol, G., Knuutila, S., Lluı́s, F., Capellá, G., Miró, R., & Caballín, M. R. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00118-1 · Cited by 58
Insulin-like Growth Factor-binding Protein-3 Activates a Phosphotyrosine Phosphatase
Ricort, J., & Binoux, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200439200 · Cited by 57
Lymphangiogenesis and tumor metastasis
Nisato, R. E., Tille, J., & Pepper, M. S. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-04-0206 · Cited by 57
The insulin‐like growth factor I receptor gene is the target for the 15q26 amplicon in breast cancer
Almeida, A., Muleris, M., Dutrillaux, B., & Malfoy, B. (1994) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870110110 · Cited by 56
Parker, A. S., Cheville, J. C., Janney, C. A., & Cerhan, J. R. (2002) · Human Pathology · doi:10.1053/hupa.2002.126186 · Cited by 56
Fiorelli, G., Orlando, C., Benvenuti, S., Franceschelli, F., Bianchi, S., Pioli, P., Tanini, A., Serio, M., Bartucci, F., & Brandi, M. L. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090307 · Cited by 56
Insulin‐like growth factor I receptors on mouse neuroblastoma cells
Ota, A., Wilson, G. L., & LeRoith, D. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb14130.x · Cited by 54
Self-citationParker, A. S., Cheville, J. C., Lohse, C. M., Cerhan, J. R., & Blute, M. L. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000071474.70103.92 · Cited by 52
Hamelers, I. H. L., van Schaik, R. F. M. A., Sipkema, J., Sussenbach, J. S., & Steenbergh, P. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208727200 · Cited by 50
Chung, C. K., & Antoniades, H. N. (1992) · PubMed · Cited by 49
Jiang, Y., Rom, W. N., Yie, T.-A., X, C., & Tchou-Wong, K.-M. (1999) · Oncogene · doi:10.1038/sj.onc.1202984 · Cited by 49
Zhang, L., Zhan, Q., Zhan, S., et al. (1998) · DNA and Cell Biology · doi:10.1089/dna.1998.17.125 · Cited by 46
Yi, H., Kim, S., Hwang, P., Kim, C. Y., Yang, D.-H., Oh, Y., & Lee, D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.045 · Cited by 44
An inhibitory function for JNK in the regulation of IGF-I signaling in breast cancer
Mamay, C. L., Mingo-Sion, A. M., Wolf, D., Molina, M. D. C., & Berg, C. L. V. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206186 · Cited by 44
Biedi, C., Panetta, D., Segat, D., Cordera, R., & Maggi, D. C. (2003) · Endocrinology · doi:10.1210/en.2003-0417 · Cited by 43
Wu, X., Tortolero‐Luna, G., Zhao, H., et al. (2003) · PubMed · Cited by 43
Sunic, D., McNeil, J. D., Rayner, T. E., Andress, D. L., & Belford, D. A. (1998) · Endocrinology · doi:10.1210/endo.139.5.5983 · Cited by 42
Lynch, L., Vodyanik, P. I., Boettiger, D. C., & Guvakova, M. A. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-05-0399 · Cited by 42
Jansson, M., Hallén, D., Koho, H., Andersson, G., Berghard, L., Heidrich, J., Nyberg, E., Uhlén, M., Kördel, J., & Nilsson, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8189 · Cited by 41
Demonstration of tumor suppression by mannose 6-phosphate/insulin-like growth factor 2 receptor
Li, J., & Sahagian, G. G. (2004) · Oncogene · doi:10.1038/sj.onc.1208039 · Cited by 40
Sekharam, M., Nasir, A., Kaiser, H. E., & Coppola, D. (2003) · PubMed · Cited by 39
Lamas, E., Bail, B. L., Housset, C., et al. (1991) · PubMed · Cited by 38
Gallicchio, M., Kaun, C., Wojta, J., et al. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10352 · Cited by 37
Dricu, A., Kanter, L., Wang, M., Nilsson, G. P., Hjertman, M., Wejde, J., & Larsson, O. (1999) · Glycobiology · doi:10.1093/glycob/9.6.571 · Cited by 37
Steele-Perkins, G., & Roth, R. A. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90819-9 · Cited by 36
Insulin-Like Growth Factor I Activates c-Jun N-Terminal Kinase in MCF-7 Breast Cancer Cells1
Monno, S., Newman, M. V., Cook, M., & Lowe, W. L. (2000) · Endocrinology · doi:10.1210/endo.141.2.7307 · Cited by 32
Bell, I. M., Stirdivant, S. M., Ahern, J. D., Culberson, J. C., Darke, P. L., Dinsmore, C. J., Drakas, R. A., Gallicchio, S. N., Graham, S. L., Heimbrook, D. C., et al. (2005) · Biochemistry · doi:10.1021/bi0500628 · Cited by 32
Shiono, S., Ishii, G., Nagai, K., et al. (2006) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2005.12.003 · Cited by 29
Chong, Y. M., Williams, S. L. J., Elkak, A. E., Sharma, A. K., & Mokbel, K. (2006) · PubMed · Cited by 29
Chernicky, C. L. (2002) · Molecular Pathology · doi:10.1136/mp.55.2.102 · Cited by 28
Gil‐Ad, I., Shtaif, B., Luria, D., Karp, L., Fridman, Y., & Weizman, A. (1999) · Growth Hormone & IGF Research · doi:10.1054/ghir.1999.0130 · Cited by 27
Lee, Y. I., Han, Y. J., Lee, S. Y., Lee, Y. I., Park, S. K., Park, Y. J., Moon, H. B., Shin, J. H., & Lee, J. H. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(03)00117-5 · Cited by 27
Alarcón, C., Cheatham, B., Lincoln, B. C., Kahn, C. R., Siddle, K., & Rhodes, C. J. (1994) · Biochemical Journal · doi:10.1042/bj3010257 · Cited by 26
Yoon, A., & Hurta, R. A. R. (2001) · Molecular and Cellular Biochemistry · doi:10.1023/a:1017549222677 · Cited by 26
Cohick, W. S., Wang, B., Verma, P., & Boisclair, Y. R. (2000) · Endocrinology · doi:10.1210/endo.141.12.7854 · Cited by 26
The Insulin-Like Growth Factor (IGF) Family and Breast Cancer
Perks, C. M., & Holly, J. M. P. (2003) · Breast Disease · doi:10.3233/bd-2003-18106 · Cited by 25
Hwang, P. H., Kim, S. Y., Lee, J. C., Kim, S. J., Yi, H. K., & Lee, D. (2005) · Experimental & Molecular Medicine · doi:10.1038/emm.2005.49 · Cited by 22
Chattopadhyay, A., & Carpenter, G. F. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.10.2233 · Cited by 21
Perks, C. M., & Holly, J. M. P. (2003) · Breast Disease · doi:10.3233/bd-2003-17109 · Cited by 12
Differential patterns of insulin‐like growth factor‐I and ‐II mRNA expression in medulloblastoma
van Doorn, J., Gilhuis, H. J., Koster, J. G., Wesseling, P., Reddingius, R. E., Gresnigt, M. G., Bloemen, R. J., van Muijen, G. N. P., & van Buul-Offers, S. C. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00571.x · Cited by 11
Cloning of the Mouse Insulin Receptor Substrate-3 (mIRS-3) Promoter, and Its Regulation by p53
Sciacchitano, S., Orecchio, A., Lavra, L., Misiti, S., Giacchini, A., Zani, M., Danese, D., Gurtner, A., Soddu, S., Mario, U. D., et al. (2002) · Molecular Endocrinology · doi:10.1210/me.16.7.1577 · Cited by 9
Cell Itinerary and Metabolic Fate of Proinsulin in Rat Liver: In Vivo and in Vitro Studies
Desbuquois, B., Chauvet, G., Kouach, M., & Authier, F. (2003) · Endocrinology · doi:10.1210/en.2002-0154 · Cited by 8
Cited by
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Liu, Z.-L., Chen, H.-H., Zheng, L.-L., Sun, L.-P., & Shi, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01460-1 · Cited by 1,300
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
Currie, C. J., Poole, C. D., & Gale, E. A. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1440-6 · Cited by 1,124
Belfiore, A., Frasca, F., Pandini, G., Sciacca, L., & Vigneri, R. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0047 · Cited by 1,033
Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892
Metadata
- Authors
- Samani, A. A., Yakar, S., LeRoith, D., & Brodt, P.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2007-02-01
- Volume
- 28
- Issue
- 1
- Pages
- 20-47
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2051839343
- Cited by
- 1,005
- References
- 260
- FWCI
- 54.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.